Recommendations for classification of commercial LBA kits for biomarkers in drug development from the GCC for bioanalysis.
- DOI
- 10.4155/bio-2019-0072
- Published
- 2019 Apr
- Container
- Bioanalysis
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.4155/bio-2019-0072,
title = {Recommendations for classification of commercial LBA kits for biomarkers in drug development from the GCC for bioanalysis.},
author = {Islam R and Kar S and Ritzén H and Hays A and Tayyem R and Barry C and Keyhani A and Zimmer J and Cruz Caturla M and Couerbe P and Warren M and Khadang A and Bourdage J and Lindley K and Williams D and Hughes N and Sheldon C and Satterwhite C and Vija J and Yu M and Boulay I and Stamatopoulos J and Lin J and Cape S and Estdale S and Thomas E and Dinan A and MacNeill R and Xiao YQ and Garofolo W and Savoie N and Brown M and Rhyne P and Hristopoulos G and Xu A and Goodwin L and Spriggs F and Xu A and Awaiye K and Hayes R and St Charles J and Bouhajib M and DiMarco C and DiMarco L and Savu SR and Bennett P and Kakkanaiah V and Nehls C and Stouffer B and Tabler E and Briscoe C and Karnik S and DuBey I and Kulagina N and Lindsay J and Beaver C and Williard C and Wang H and Feng H and Malone M and Wells E and Fang X and Moussallie M},
year = {2019},
journal = {Bioanalysis},
doi = {10.4155/bio-2019-0072},
url = {https://doi.org/10.4155/bio-2019-0072}
}RIS
TY - JOUR TI - Recommendations for classification of commercial LBA kits for biomarkers in drug development from the GCC for bioanalysis. AU - Islam R AU - Kar S AU - Ritzén H AU - Hays A AU - Tayyem R AU - Barry C AU - Keyhani A AU - Zimmer J AU - Cruz Caturla M AU - Couerbe P AU - Warren M AU - Khadang A AU - Bourdage J AU - Lindley K AU - Williams D AU - Hughes N AU - Sheldon C AU - Satterwhite C AU - Vija J AU - Yu M AU - Boulay I AU - Stamatopoulos J AU - Lin J AU - Cape S AU - Estdale S AU - Thomas E AU - Dinan A AU - MacNeill R AU - Xiao YQ AU - Garofolo W AU - Savoie N AU - Brown M AU - Rhyne P AU - Hristopoulos G AU - Xu A AU - Goodwin L AU - Spriggs F AU - Xu A AU - Awaiye K AU - Hayes R AU - St Charles J AU - Bouhajib M AU - DiMarco C AU - DiMarco L AU - Savu SR AU - Bennett P AU - Kakkanaiah V AU - Nehls C AU - Stouffer B AU - Tabler E AU - Briscoe C AU - Karnik S AU - DuBey I AU - Kulagina N AU - Lindsay J AU - Beaver C AU - Williard C AU - Wang H AU - Feng H AU - Malone M AU - Wells E AU - Fang X AU - Moussallie M PY - 2019 JO - Bioanalysis DO - 10.4155/bio-2019-0072 UR - https://doi.org/10.4155/bio-2019-0072 ER -
APA
R, I., S, K., H, R., A, H., R, T., C, B., A, K., J, Z., M, C. C., P, C., M, W., A, K., J, B., K, L., D, W., N, H., C, S., C, S., J, V., M, Y., I, B., J, S., J, L., S, C., S, E., E, T., A, D., R, M., YQ, X., W, G., N, S., M, B., P, R., G, H., A, X., L, G., F, S., A, X., K, A., R, H., J, S. C., M, B., C, D., L, D., SR, S., P, B., V, K., C, N., B, S., E, T., C, B., S, K., I, D., N, K., J, L., C, B., C, W., H, W., H, F., M, M., E, W., X, F., & M, M. (2019). Recommendations for classification of commercial LBA kits for biomarkers in drug development from the GCC for bioanalysis.. Bioanalysis. https://doi.org/10.4155/bio-2019-0072
Source records
- pubmed · retrieved 2026-09-25T23:38:29.514Z